Trial Profile

A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 in Active Plaque Psoriasis

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 03 Feb 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dalazatide (Primary)
Indications Plaque psoriasis
Focus Adverse reactions; Proof of concept
Sponsors Kineta

Most Recent Events

09 Jun 2015 As per a Kineta media release, results from this trial will be presented at the Biotechnology Industry Organization (BIO) Annual Meeting in Philadelphia.
05 May 2015 Results were published in a Kineta media release.
05 May 2015 According to a Kineta media release, results from biomarker analysis of this study are expected to be available in the second quarter of 2015.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com